Nuzenio

Month Interim Safety

Month Interim Safety news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 5 publisher sources 100/100 entity strength

Latest news

ProMIS Neurosciences Reports Positive 6-Month Interim Safety and Biomarker Results for PMN310 in Phase 1b Alzheimer’s Trial - Quiver QuantitativeQuiver Quantitative · Tue, 28 Jul 2026 10:13:00 GMTProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - globenewswire.comglobenewswire.com · Tue, 28 Jul 2026 10:00:00 GMTProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results - Yahoo FinanceYahoo Finance · Tue, 28 Jul 2026 07:00:00 GMTPMN: Interim results show strong safety and biomarker improvements for PMN310 in Alzheimer's disease - TradingViewTradingView · Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences (Nasdaq: PMN) reports positive six-month PMN310 Alzheimer’s trial data - Stock TitanStock Titan · Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences to Host Webinar to Discuss Upcoming - globenewswire.comglobenewswire.com · Mon, 27 Jul 2026 07:00:00 GMT

Timeline

Tue, 28 Jul 2026 10:13:00 GMTProMIS Neurosciences Reports Positive 6-Month Interim Safety and Biomarker Results for PMN310 in Phase 1b Alzheimer’s Trial - Quiver Quantitative
Tue, 28 Jul 2026 10:00:00 GMTProMIS Neurosciences Reports Positive Blinded Six-Month Interim Safety and Biomarker Data for PMN310 in the PRECISE-AD Phase 1b Alzheimer’s Disease Trial - globenewswire.com
Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences Shares Climb on Positive Interim Alzheimer’s Trial Safety Results - Yahoo Finance
Tue, 28 Jul 2026 07:00:00 GMTPMN: Interim results show strong safety and biomarker improvements for PMN310 in Alzheimer's disease - TradingView
Tue, 28 Jul 2026 07:00:00 GMTProMIS Neurosciences (Nasdaq: PMN) reports positive six-month PMN310 Alzheimer’s trial data - Stock Titan
Mon, 27 Jul 2026 07:00:00 GMTProMIS Neurosciences to Host Webinar to Discuss Upcoming - globenewswire.com

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Month Interim Safety.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

5 distinct publisher/source names are currently connected to this entity page.